Aspergillus species strain m39 produces two naphtho‐γ‐pyrones that reverse drug resistance in human KB cells

Shun‐Ichi ‐I Ikeda, Masanori Sugita, Akihiko Yoshimura, Tomoyuki Sumizawa, Haruhiko Douzono, Yukihiro Nagata, Shin‐Ichi ‐I Akiyama

研究成果: Article査読

30 被引用数 (Scopus)

抄録

One thousand fungi and Actinomycetes were investigated to see whether they produced compounds that reverse multidrug resistance in KB cells. Only one Aspergillus strain M39 produced agents with resistance‐reversing activity and these compounds were identified to be rubrofusarin B and dianhydro‐aurasperone C. Rubrofusarin B only slightly reversed the resistance of KB‐C2 cells to Adriamycin and daunomycin, partially reversed the resistance to chromomycin A3, and almost completely reversed the resistance to vincristine and mitomycin C. Purified dianhydro‐aurasperone C and rubrofusarin B had similar effects on drug resistance in KB‐8‐5 cells. Dianhydro‐aurasperone C enhanced the accumulation of vinblastine in KB‐8‐5 cells and inhibited the efflux of vinblastine from the cells. Dianhydro‐aurasperone C and rubrofusarin B at 10 μ M completely inhibited 3H‐azidopine photolabelling of P‐glycoprotein. The two products of Aspergillus strain M39 appear to reverse multi‐drug resistance by interacting with P‐glycoprotein and inhibiting its role as an active efflux pump.

本文言語English
ページ(範囲)508-513
ページ数6
ジャーナルInternational Journal of Cancer
45
3
DOI
出版ステータスPublished - 1990 3月 15
外部発表はい

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「Aspergillus species strain m39 produces two naphtho‐γ‐pyrones that reverse drug resistance in human KB cells」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル